Thank you for your interest in our webinar series Advances in Protein Degradation. The webinars have now passed, but please take advantage of the recordings and Q&A’s posted below.
Since 2015 the field of targeted protein degradation has rapidly emerged, offering opportunities for novel pharmacological interventions in ways impossible to achieve with traditional small molecule inhibitors. This webinar focuses on cutting-edge drug discovery using protein degraders, such as PROTACS, in diverse therapeutic areas. Attendees can expect to learn about recent strategies toward development of orally bioavailable protein degrader drug candidates—PROTACs and beyond.
|Accelerated Development: Fast path to the clinic||Discovery & preclinical approaches that enable rapid development|
|Enhanced Bioavailability||Approaches that enhance solubility of challenging API to enable clinically viable formulations|
|Continuous Processing||Topics covered will include uses of technologies such as: amorphous solid dispersion, continuous granulation, coating and extrusion|
|Oral Delivery||Innovative approaches to address oral delivery of biologics, including: proteins, peptides, nucleic acids, and beyond|